These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28120767)

  • 1. [A new toolbox for genome editing].
    Jordan B
    Med Sci (Paris); 2017 Jan; 33(1):105-108. PubMed ID: 28120767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new milestone in human embryo editing].
    Jordan B
    Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Mediated Base Editing without DNA Double-Strand Breaks.
    Plosky BS
    Mol Cell; 2016 May; 62(4):477-8. PubMed ID: 27203175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene editing flows to the lungs.
    Bulcaen M; Carlon MS
    Science; 2024 Jun; 384(6701):1175-1176. PubMed ID: 38870313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found.
    Carlson B
    Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing.
    Maule G; Arosio D; Cereseto A
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The New Frontiers in Cancer.
    Batista A
    Trends Cancer; 2016 Oct; 2(10):533. PubMed ID: 28741481
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium.
    McNeer NA; Anandalingam K; Fields RJ; Caputo C; Kopic S; Gupta A; Quijano E; Polikoff L; Kong Y; Bahal R; Geibel JP; Glazer PM; Saltzman WM; Egan ME
    Nat Commun; 2015 Apr; 6():6952. PubMed ID: 25914116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
    Luo J
    Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating Cystic Fibrosis with mRNA and CRISPR.
    Da Silva Sanchez A; Paunovska K; Cristian A; Dahlman JE
    Hum Gene Ther; 2020 Sep; 31(17-18):940-955. PubMed ID: 32799680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair.
    Economos NG; Oyaghire S; Quijano E; Ricciardi AS; Saltzman WM; Glazer PM
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Gene-Editing Tool Slowly Advances Into the Clinic.
    Jenks S
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117363
    [No Abstract]   [Full Text] [Related]  

  • 16. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
    Merkert S; Martin U
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing: A breakthrough in life science and medicine.
    Hatada I; Horii T
    Endocr J; 2016; 63(2):105-10. PubMed ID: 26698412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing.
    Ricciardi AS; Quijano E; Putman R; Saltzman WM; Glazer PM
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29534473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marker-free coselection for CRISPR-driven genome editing in human cells.
    Agudelo D; Duringer A; Bozoyan L; Huard CC; Carter S; Loehr J; Synodinou D; Drouin M; Salsman J; Dellaire G; Laganière J; Doyon Y
    Nat Methods; 2017 Jun; 14(6):615-620. PubMed ID: 28417998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.